Loading…

2122 Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The MACRO-2 trial

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) 2015-09, Vol.51, p.S371-S372
Main Authors:	Aranda, E, García-Alfonso, P, Benavides, M, Sanchez-Ruiz, A, Guillen-Ponce, C, Safont, M.J, Alcaide, J, Gomez, A, Lopez, R, Manzano, J.L, Mendez-Urena, M, Lopez, C, García-Paredes, B, Grávalos, C, García-García, T, Falco, E, Martin-Valades, J.I, Gonzalez-Flores, E, Navalon, M, Diaz-Rubio, E
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!